What is the recommended treatment for gonorrhea?

The recommended treatment for gonorrhea involves a dual therapy approach using Rocephin (ceftriaxone) administered intramuscularly along with Azithromycin taken orally. This combination is effective because it addresses gonorrhea while also providing coverage against potential co-infection with chlamydia, which is common in patients diagnosed with gonorrhea.

The use of Rocephin 250 mg IM is effective in achieving high concentrations at the site of infection, while Azithromycin works to eliminate chlamydial co-infection. This approach is recommended by health organizations to ensure a comprehensive treatment method that enhances eradication rates of both pathogens.

The efficacy of this dual therapy, along with considerations for rising antibiotic resistance, emphasizes the importance of using both medications as part of the recommended treatment protocol. This strategy aligns with guidelines that aim to reduce complications and the potential for antibiotic resistance, making the combination of Rocephin and Azithromycin the gold standard in treating gonorrhea.

Other treatments listed do not align with the current recommendations. For example, utilizing only doxycycline or azithromycin alone does not provide the necessary coverage for gonococcal infections and could lead to inadequate treatment.